<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0005065"><a href="http://purl.obolibrary.org/obo/MONDO_0005065">MONDO:0005065</a></h3>
<p><strong>Label:</strong> mesothelioma</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0006292">MONDO:0006292</a> (malignant mesothelioma (disease)),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_156240">OMIM:156240</a>, <a href="http://www.orpha.net/ORDO/Orphanet_50251">Orphanet:50251</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0100001">HP:0100001</a> (Malignant mesothelioma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0100001">HP:0100001</a> (Malignant mesothelioma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0100001">HP:0100001</a> (Malignant mesothelioma) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 36.47%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 35.66%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) and <a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) 34.45%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) 34.28%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 28.56%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 28.36%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 27.49%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 27.38%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) 26.02%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 25.82%</li>
<li>Thing 25.82%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 25.82%</li>
</ul>
</body>
</html>
